Serina Therapeutics (SER) Interest Expenses (2017 - 2026)
Serina Therapeutics (SER) posted Interest Expenses of $172000.0 for Q4 2025, up 616.67% sequentially from $24000.0 in Q3 2025, and down 52.22% YoY from $360000.0 in Q4 2024.
Serina Therapeutics (SER) Interest Expenses (2017 - 2026) Analysis & Trends
Serina Therapeutics has reported Interest Expenses for 9 years, with the latest figure at $172000.0 in Q4 2025.
- Quarterly Interest Expenses fell 52.22% year-over-year to $172000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $438000.0 (up 17.11% YoY) and the FY2025 annual result came in at $44.2 million, up 8298.1% from the prior year.
- Interest Expenses improved to $172000.0 in Q4 2025 per SER's latest filing, from $24000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $923000.0 in Q3 2022 and troughed at -$194000.0 in Q4 2023.
- A 5-year average of $308277.8 and a median of $228500.0 in 2021 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2021 and 2022: Interest Expenses sank 98.2% in 2021, then soared 21475.0% in 2022.
- Over 5 years, Interest Expenses stood at $285000.0 in 2021, then soared by 223.86% to $923000.0 in 2022, then plunged by 121.02% to -$194000.0 in 2023, then soared by 285.57% to $360000.0 in 2024, then plunged by 52.22% to $172000.0 in 2025.
- According to Business Quant data, Interest Expenses over the past three periods registered $172000.0, $24000.0, and $391000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 82.05 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -4.89 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 20.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 93.62 Mn |
| 10 | Serina Therapeutics | 46.70 Mn | 23.67 Mn | - | 203,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.95 Mn |
| Jun 30, 2026 | 1.95 Mn |
| Dec 31, 2025 | 172,000.00 |
| Dec 31, 2025 | 172,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Jun 30, 2025 | 391,000.00 |
| Jun 30, 2025 | 391,000.00 |
| Mar 31, 2025 | 433,000.00 |
| Mar 31, 2025 | 433,000.00 |
| Dec 31, 2024 | 360,000.00 |
| Dec 31, 2024 | 360,000.00 |
| Sep 30, 2024 | 117,000.00 |
| Sep 30, 2024 | 117,000.00 |
| Jun 30, 2024 | 616,000.00 |
| Jun 30, 2024 | 616,000.00 |
| Mar 31, 2024 | 683,000.00 |
| Mar 31, 2024 | 683,000.00 |
| Dec 31, 2023 | -194,000.00 |
| Dec 31, 2023 | -194,000.00 |